GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 94 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 1.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $119,422 | -12.1% | 69,431 | -0.3% | 0.00% | – |
| Q2 2023 | $135,823 | -30.2% | 69,647 | -0.5% | 0.00% | – |
| Q1 2023 | $194,592 | -17.9% | 69,999 | +1.8% | 0.00% | – |
| Q4 2022 | $237,135 | +31.7% | 68,733 | -1.8% | 0.00% | – |
| Q3 2022 | $180,000 | +25.0% | 69,987 | +17.7% | 0.00% | – |
| Q2 2022 | $144,000 | -43.8% | 59,471 | -4.3% | 0.00% | – |
| Q1 2022 | $256,000 | -69.1% | 62,128 | -3.6% | 0.00% | -100.0% |
| Q4 2021 | $829,000 | -6.7% | 64,478 | -21.6% | 0.00% | 0.0% |
| Q3 2021 | $889,000 | +50.2% | 82,288 | +27.0% | 0.00% | 0.0% |
| Q2 2021 | $592,000 | +73.1% | 64,799 | +78.5% | 0.00% | 0.0% |
| Q1 2021 | $342,000 | – | 36,299 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,561,150 | $6,125,178 | 3.26% |
| Redmile Group, LLC | 8,509,126 | $14,635,697 | 0.70% |
| Avidity Partners Management LP | 2,733,800 | $4,702,136 | 0.19% |
| Frazier Life Sciences Management, L.P. | 1,430,878 | $2,461,110 | 0.16% |
| Artia Global Partners LP | 95,170 | $163,692 | 0.07% |
| Worth Venture Partners, LLC | 43,772 | $75,288 | 0.04% |
| SkyOak Wealth, LLC | 60,875 | $104,705 | 0.03% |
| Point72 Asset Management, L.P. | 5,924,867 | $10,190,771 | 0.03% |
| CORNERCAP INVESTMENT COUNSEL INC | 76,811 | $132,115 | 0.02% |
| Houlihan Financial Resource Group, Ltd. | 20,000 | $38 | 0.02% |